• ARAZLO Lotion, 0.045% for Acne Now Available in the U.S

    1 month ago - By Surgical Aesthetics Magazine

    Ortho Dermatologics ARAZLO Lotion, 0.045%, is now commercially available to healthcare professionals in the United States. The U.S. Food and Drug Administration approved the topical in December 2019. ARAZLO is the first tazarotene acne treatment available in lotion formulation.
    “Retinoids like tazarotene are highly effective in treating acne and considered a cornerstone of acne treatment, but often are perceived to be associated with skin irritation. Clinical studies have demonstrated that ARAZLO's proprietary formulation provides the proven efficacy of a retinoid in a lotion that is more...
    Read more ...